%0 Journal Article %T Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study %D 2020 %R 10.1136/jitc-2019-000437corr1 %J Journal for ImmunoTherapy of Cancer %P e000437corr1 %V 8 %N 2 %U https://jitc.bmj.com/content/jitc/8/2/e000437corr1.full.pdf